Belén Blanco

2.1k total citations
40 papers, 1.6k citations indexed

About

Belén Blanco is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Belén Blanco has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Immunology and 12 papers in Hematology. Recurrent topics in Belén Blanco's work include CAR-T cell therapy research (16 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Belén Blanco is often cited by papers focused on CAR-T cell therapy research (16 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Belén Blanco collaborates with scholars based in Spain, United States and United Kingdom. Belén Blanco's co-authors include Luis Álvarez‐Vallina, Jesús F. San Miguel, Josè Antonio Pérez-Simón, Consuelo del Cañizo, Luís I. Sánchez-Abarca, Fermín Sánchez‐Guijo, Laura Sanz, María Díez‐Campelo, Soraya Carrancio and Soraya Tabera and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Belén Blanco

38 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Belén Blanco Spain	21	540	507	497	467	464	40	1.6k
Rebekka Wehner Germany	27	652 1.2×	276 0.5×	990 2.0×	941 2.0×	507 1.1×	66	2.2k
Simon N. Robinson United States	22	378 0.7×	589 1.2×	576 1.2×	511 1.1×	443 1.0×	66	1.5k
Marek Honczarenko United States	21	586 1.1×	488 1.0×	1.0k 2.1×	720 1.5×	682 1.5×	31	2.2k
Ivana Pierri Italy	22	268 0.5×	577 1.1×	762 1.5×	601 1.3×	447 1.0×	72	2.0k
Lora W. Barsky United States	27	780 1.4×	419 0.8×	531 1.1×	352 0.8×	340 0.7×	39	2.1k
Judith A. Shizuru United States	8	578 1.1×	517 1.0×	583 1.2×	255 0.5×	273 0.6×	10	1.5k
Patrizia Zucchini Italy	22	470 0.9×	445 0.9×	307 0.6×	182 0.4×	453 1.0×	56	1.4k
Myrtle Y. Gordon United Kingdom	22	914 1.7×	1.0k 2.0×	511 1.0×	494 1.1×	612 1.3×	60	2.3k
Susan Prohaska United States	13	678 1.3×	569 1.1×	853 1.7×	365 0.8×	227 0.5×	15	1.7k
Brandon Harder United States	14	372 0.7×	246 0.5×	634 1.3×	332 0.7×	172 0.4×	19	1.4k

Countries citing papers authored by Belén Blanco

Since Specialization

Citations

This map shows the geographic impact of Belén Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belén Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belén Blanco more than expected).

Fields of papers citing papers by Belén Blanco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belén Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belén Blanco. The network helps show where Belén Blanco may publish in the future.

Co-authorship network of co-authors of Belén Blanco

This figure shows the co-authorship network connecting the top 25 collaborators of Belén Blanco. A scholar is included among the top collaborators of Belén Blanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belén Blanco. Belén Blanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiménez-Reinoso, Anaïs, Cristina Cirauqui, Belén Blanco, et al.. (2024). CD4 ⁺ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts. OncoImmunology. 13(1). 2392897–2392897. 5 indexed citations

Martín-Antonio, Beatriz, Belén Blanco, África González‐Murillo, et al.. (2024). Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations. Frontiers in Immunology. 15. 1386856–1386856. 10 indexed citations

Compte, Marta, Rocío Navarro, Antonio Tapia‐Galisteo, et al.. (2022). Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity. iScience. 25(9). 104958–104958. 12 indexed citations

Blanco, Belén, Ángel Ramírez-Fernández, & Luis Álvarez‐Vallina. (2020). Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies. Frontiers in Immunology. 11. 1792–1792. 15 indexed citations

Almeida, Júlia, Laura San‐Segundo, Susana Inogés, et al.. (2016). Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development. Journal of Hematology & Oncology. 9(1). 113–113. 81 indexed citations

Blanco, Belén, et al.. (2015). Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms. Immunologic Research. 62(2). 175–188. 12 indexed citations

Blanco, Belén, et al.. (2015). Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function. International Immunopharmacology. 28(1). 675–685. 11 indexed citations

Santamaría, Carlos, Sandra Muntión, Beatriz Rosón, et al.. (2012). Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients. Haematologica. 97(8). 1218–1224. 86 indexed citations

Rica, Lorenzo de la, Esteban Ballestar, Carlos Santamaría, et al.. (2012). Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment. Leukemia Research. 36(7). 895–899. 13 indexed citations

10.

Carrancio, Soraya, Belén Blanco, Carlos G. Romo, et al.. (2011). Bone Marrow Mesenchymal Stem Cells for Improving Hematopoietic Function: An In Vitro and In Vivo Model. Part 2: Effect on Bone Marrow Microenvironment. PLoS ONE. 6(10). e26241–e26241. 38 indexed citations

11.

Pérez-Simón, Josè Antonio, Teresa Caballero‐Velázquez, Teresa Flores, et al.. (2010). Limbus Damage in Ocular Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 17(2). 270–273. 26 indexed citations

12.

Pérez-Simón, Josè Antonio, Soraya Tabera, María Eugenia Sarasquete, et al.. (2009). Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura. Cytotherapy. 11(6). 698–705. 56 indexed citations

13.

Sánchez‐Guijo, Fermín, Juan F. Blanco, Sandra Muntión, et al.. (2009). Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects. Cell and Tissue Research. 336(3). 501–507. 25 indexed citations

14.

Compte, Marta, Belén Blanco, Fernando E. Serrano, et al.. (2007). Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA × anti-CD3 diabodies from lentivirally transduced human lymphocytes. Cancer Gene Therapy. 14(4). 380–388. 50 indexed citations

15.

Villarón, Eva M., Júlia Almeida, Natalia López-Holgado, et al.. (2007). In leukapheresis products from non-Hodgkin’s lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression. Transfusion and Apheresis Science. 37(2). 145–156. 5 indexed citations

16.

López-Holgado, Natalia, Mercedes Alberca, Fermín Sánchez‐Guijo, et al.. (2006). Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. Cytotherapy. 9(1). 14–22. 23 indexed citations

17.

Blanco, Belén, et al.. (2003). Induction of Human T Lymphocyte Cytotoxicity and Inhibition of Tumor Growth by Tumor-Specific Diabody-Based Molecules Secreted from Gene-Modified Bystander Cells. The Journal of Immunology. 171(2). 1070–1077. 44 indexed citations

18.

Sanz, Laura, et al.. (2002). Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices. Gene Therapy. 9(15). 1049–1053. 47 indexed citations

19.

Álvarez‐Vallina, Luis, Rosa María Pérez Yáñez, Belén Blanco, Magdalena Gil, & Stephen J. Russell. (2000). Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors. Cancer Gene Therapy. 7(4). 526–529. 9 indexed citations

20.

Blanco, Belén, M. Del Rı́o, Víctor M. Víctor, et al.. (1999). Effect of a diet supplemented with thioproline on murine macrophage function in a model of premature ageing. BioFactors. 10(2-3). 195–200. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact